Literature DB >> 3529019

Magnetic resonance imaging in occult spinal dysraphism.

R A Roos, G J Vielvoye, J H Voormolen, A C Peters.   

Abstract

The value of magnetic resonance imaging (MRI), compared to myelography and computerized tomography, is illustrated in six patients with occult spinal dysraphism. MRI proved to be the diagnostic tool of choice.

Entities:  

Mesh:

Year:  1986        PMID: 3529019     DOI: 10.1007/bf02386821

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  6 in total

1.  The tethered conus.

Authors:  C R Fitz; D C Harwood Nash
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1975-11

2.  MYELOGRAPHIC ASSESSMENT OF OCCULT FORMS OF SPINAL DYSRAPHISM.

Authors:  G L GRYSPEERDT
Journal:  Acta Radiol Diagn (Stockh)       Date:  1963-05

3.  Spinal dysraphism: a study of congenital malformations of the back.

Authors:  K Till
Journal:  Dev Med Child Neurol       Date:  1968-08       Impact factor: 5.449

4.  Occult spinal dysraphism: a series of 73 cases.

Authors:  F M Anderson
Journal:  Pediatrics       Date:  1975-06       Impact factor: 7.124

5.  Computed tomography in spinal dysraphism.

Authors:  H E James; M Oliff
Journal:  J Comput Assist Tomogr       Date:  1977-10       Impact factor: 1.826

6.  Tethered cord syndrome in adults.

Authors:  D Pang; J E Wilberger
Journal:  J Neurosurg       Date:  1982-07       Impact factor: 5.115

  6 in total
  3 in total

Review 1.  Dysraphic problems in the lumbar spine: dilemmas in management--a review of 49 cases.

Authors:  K M Morris; G F Findlay
Journal:  Eur Spine J       Date:  1992-09       Impact factor: 3.134

2.  Magnetic resonance evaluation of spinal dysraphism in children.

Authors:  R K Gupta; A Sharma; A Jena; G Tyagi; B Prakash; S Khushu
Journal:  Childs Nerv Syst       Date:  1990-05       Impact factor: 1.475

3.  Occult spinal dysraphism: neuroradiological study.

Authors:  P Tortori-Donati; A Cama; M L Rosa; L Andreussi; A Taccone
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.